Antipsychotic Treatment Patterns in Belgian Schizophrenia Patients
Author Information
Author(s): Hanssens L, De Hert M, Wampers M, Reginster J-Y, Peuskens J
Primary Institution: Université de Liège
Hypothesis
To evaluate the use and dose of atypical antipsychotics in ambulatory patients with schizophrenia in Belgium.
Conclusion
Atypical antipsychotics are the first line treatment for schizophrenia, and psychiatrists generally follow treatment guidelines adequately.
Supporting Evidence
- 69% of patients are treated with atypical antipsychotics.
- 73% of patients receive only one antipsychotic drug.
- The majority of patients are treated with either first-typical or second-generation atypical antipsychotics.
Takeaway
Doctors in Belgium mostly give one type of medicine to help people with schizophrenia, and they often choose the newer medicines that have fewer side effects.
Methodology
A cross-sectional survey was conducted in 16 Belgian hospitals, collecting data on medication use and demographics from 1000 ambulatory patients with schizophrenia.
Potential Biases
Potential bias in self-reported medication adherence and clinician reporting.
Limitations
The study may not fully represent all treatment practices across Belgium due to the limited number of hospitals surveyed.
Participant Demographics
The majority of participants were male (64.1%), unemployed (79.5%), with a mean age of 40.5 years.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website